Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 15, 2021 07:00 ET | Source: CareDx, Inc.

CareDx to Report Second Quarter 2021 Financial Results

SOUTH SAN FRANCISCO, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
July 01, 2021 16:01 ET | Source: CareDx, Inc.

CareDx Transplant Patient App, AlloCare, Expands Access to the Majority of Transplant Patients

SOUTH SAN FRANCISCO, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 30, 2021 07:00 ET | Source: CareDx, Inc.

CareDx Appoints Dr. Hannah Valantine to its Board of Directors

Dr. Valantine brings deep transplant and diversity leadership expertise to the CareDx board SOUTH SAN FRANCISCO, Calif., June 30, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading...
June 17, 2021 07:00 ET | Source: CareDx, Inc.

CareDx CEO Reg Seeto to Present at AAKP 4th Annual Policy Summit

SOUTH SAN FRANCISCO, Calif., June 17, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 16, 2021 07:00 ET | Source: CareDx, Inc.

CareDx to Participate in Raymond James 2021 Human Health Innovation Conference

SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 15, 2021 07:00 ET | Source: CareDx, Inc.

CareDx Hosts Fireside Chat with Pro Golfer and Heart Transplant Recipient Erik Compton

SOUTH SAN FRANCISCO, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 09, 2021 07:00 ET | Source: CareDx, Inc.

CareDx congratulates Hannah Valantine for her State of the Art Lecture at ATC on Transplant Equity

SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 08, 2021 07:00 ET | Source: CareDx, Inc.

CareDx To Acquire Transplant Hero Medication Management Application

SOUTH SAN FRANCISCO, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 07, 2021 07:00 ET | Source: CareDx, Inc.

CareDx Presents Landmark KOAR-1000 Data, Demonstrating Higher 1-Year Graft Survival and Reduction in Biopsies through ARTS Surveillance

SOUTH SAN FRANCISCO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...
June 04, 2021 07:00 ET | Source: CareDx, Inc.

CareDx Presents Groundbreaking AlloSure® Data at the 2021 American Transplant Congress

SOUTH SAN FRANCISCO, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of...